Results: At the last available visit after treatment, we obtained an SE of 60.50 D in 85.71% of eyes with bipolar disorder, 88.52% of eyes with schizophrenia, and 93.75% of eyes with obsessive-compulsive disorder. The efficacy index was 1.00 6 0.20 in the first group, 1.03 6 0.21 in the second group, and 1.00 6 0.07 in the third group. No eye lost 2 lines or more of best spectacle-corrected visual acuity.
L aser in situ keratomileusis (LASIK) is one of the most commonly performed and successful surgical procedures. However, approximately 5% of patients are not satisfied with the results: poor postoperative uncorrected visual acuity (UCVA), dry eye, pain, halos, glare, and decreased visual acuity (VA) at night have been reported to be among the common causes of patient dissatisfaction after LASIK. 1, 2 Postoperative complaints after LASIK have also been attributed to unrealistic patient expectations, patient personality, and psychopathologic conditions, such as preoperative depression. 3 Patients with psychiatric disorders may express dissatisfaction with surgical results. Depressive individuals have been shown to have poorer outcomes after surgery, including coronary artery bypass grafting, traumatological procedures, digestive procedures, and aesthetic surgery. [4] [5] [6] [7] [8] [9] Some psychiatric conditions seem to be particularly related to a higher rate of post-LASIK complications. These include flap dislocation after abnormal rubbing in patients with obsessivecompulsive disorder or borderline mental illness. 10, 11 The aim of this study was to evaluate the results of surgery in patients with psychiatric disorders who underwent LASIK. The hypothesis was that patients with psychological illnesses would report lower levels of VA, poorer outcome, and more perioperative complications. The results are intended to provide general guidance for the refractive surgeon treating patients with psychiatric disorders.
PATIENTS AND METHODS
The present study evaluated the clinical records of a private ophthalmologic institution (Clínica Baviera) with 22 centers and 70 surgeons throughout Spain. From October 2002 to December 2008, we retrospectively analyzed the clinical history of 82 patients (156 eyes) who had undergone consecutively myopic LASIK and were diagnosed with bipolar disorder (79 eyes of 42 patients), schizophrenia (61 eyes of 32 patients), or obsessive-compulsive disorder (16 eyes of 8 patients). This group of patients represented 0.3% of all myopic LASIK procedures performed during this period.
We did not study patients with depression or anxiety because many patients who wish to undergo LASIK are taking antidepressants, sedatives, or tranquilizers without a confirmed psychiatric diagnosis. The 3 diseases we studied were considered when there was a validated diagnosis with a psychiatric medical report.
Apart from the psychiatric disease, the inclusion criteria were age 23 years or older and stable refraction for at least 2 years. The exclusion criteria were topographic evidence of keratoconus, active ocular disease, pregnancy, and severe medical condition.
Patients were asked to obtain their psychiatrist's permission to undergo surgery. The surgeons did not talk to the psychiatrists personally. Informed consent was obtained from all patients who were legally able at the time of surgery.
Up to 30 different surgeons performed the primary LASIK procedures. All of them followed the same standardized preoperative protocol: UCVA, subjective correction with and without cycloplegia, best-corrected visual acuity, biomicroscopy, tonometry, binocular ophthalmoscopy, ultrasonic pachymetry (DGH Technology, Inc), keratometry, and corneal topography (Orbscan; Orbtek, Inc).
The same surgical protocol was used in all eyes. Topical anesthesia (tetracaine) and the Moria LSK One manual microkeratome were used in all patients. A nasal hinged corneal flap was created using Moria's H or -1 suction rings and 100-or 130-mm plates. The Technolas Keracor 217 Z excimer laser (PlanoScan program; Bausch & Lomb) was used to perform the corneal ablation, and a 6.0-mm optical zone (with a peripheral transition zone of 9.0 mm) was programmed in all cases.
Postoperative treatment involved topical tobramycindexamethasone eye drops for 1 week and lubricant tears for several months. Follow-up was at least 3 months in every case (bipolar group, 149.63 6 94.55 days; schizophrenic group, 149.95 6 137.35 days; and obsessive-compulsive group, 144.44 6 82.87 days).
Visual Result and Predictability Indicators
We analyzed the following parameters: Efficacy: percentage of eyes with a postoperative UCVA that was equal to or better than the preoperative best spectaclecorrected visual acuity (BSCVA). The efficacy index was calculated as postoperative UCVA/preoperative BSCVA. Safety: percentage of eyes that lost more than 2 lines (Snellen) of BSCVA after the procedure compared with the preoperative BSCVA. The safety index was calculated as postoperative BSCVA/preoperative BSCVA. Predictability: percentage of eyes within 61.00 D [spherical equivalent (SE)] of the intended correction after the procedure.
These parameters were recorded using the last refraction available after treatment and the refraction recorded at the most recent examination.
Subjective Assessment From the Patient's Perspective
At least 3 months after surgery, we gave a questionnaire to the patients. The patients were asked to fill in the questionnaire and give it back personally or to send it by mail. However, not all surveys were returned. We analyzed the following parameters:
Satisfaction with treatment: percentage of patients who ranked the treatment as 8/10 or better (on a scale of 0 to 10 All the patients with bipolar disorder were taking lithium. Among the schizophrenic patients, 9 were taking olanzapine, 6 haloperidol, 2 risperidone, 2 fluphenazine, 1 perphenazine, 1 ziprasidone, 1 clozapine, and 1 zuclopenthixol. Further details on drugs taken by the patients are unavailable because data were missing from the records in some cases.
The preoperative data were rather homogeneous in all groups. The presurgery average manifest SE (around 24 6 2), mean spherical refraction, mean astigmatism (around 21 6 1), and mean keratometry are shown in Table 2 .
The mean preoperative and postoperative UCVA is shown in Table 2 and Figure 1 . 12 More than 80% of patients achieved UCVA of 20/20 or better after surgery.
The mean preoperative and postoperative BSCVA is shown in Table 2 and Figure 2. 12 Only 2.5% of bipolar disorder Table 3 . Efficacy was more than 78% in all groups; none of the patients lost more than 2 lines of VA.
Predictability is shown in Table 3 and Figures 3 and 4 .
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It was more than 96% in the total group of psychiatric patients. The efficacy index was 1.00 6 0.20 in the first group, 1.03 6 0.21 in the second group, and 1.00 6 0.07 in the third group. Post-LASIK SE was 60.50 in more than 80% of eyes and 61 in nearly 100% of eyes (Fig. 3) . Post-LASIK defocus equivalent was ,1 D in more than 90% (Fig. 4) .
No serious complications (eg, infections, diffuse lamellar keratitis, slipped/displaced flap, epithelial ingrowth) were recorded during or after surgery. Two eyes were enhanced in the bipolar group and 3 eyes in the schizophrenic group; no enhancement was performed in the obsessive-compulsive group.
Data on satisfaction are shown in Table 4 . Sixty-two of the 82 patients (75%) answered our questionnaire. The rate of satisfaction with the results was especially good in the schizophrenia group. More than 97% stated that their quality of life had improved and would undergo surgery again.
DISCUSSION
Previous research on LASIK in patients with psychiatric conditions has focused either on the preoperative profile of the patient seeking LASIK 13, 14 or on patient satisfaction after the procedure.
3,15-17 To our knowledge, no published studies have investigated the clinical outcome of psychiatric patients after LASIK.
Although this is a retrospective study involving many centers and surgeons, data collection and classification were consistent because every surgeon used the same protocol, the same questionnaire, and the same software to record the clinical history. Consequently, there were no missing data in the calculation of the visual results and predictability indicators.
We show the results obtained after LASIK in patients diagnosed with schizophrenia, bipolar disease, or obsessivecompulsive disorder. Patients with depressive symptoms were excluded (see Patients and Methods). We found that patients with compensated psychiatric disorders, of which the surgeon was aware, achieved excellent results after surgery, with no remarkable complications. The association observed between depression and poor postoperative outcome 3 may be because of the fact that these individuals were not stable: the results might have been better if the depressive symptoms had been treated in advance. Our results are similar to those of other articles studying LASIK for myopia in general population. 18, 19 In our study, the patients had already received a psychiatric diagnosis, which they reported to the ophthalmic surgeon. They were therefore aware of their disease, and this was indicative of a favorable prognosis. We believe that the ophthalmic surgeon must ensure that a patient with psychiatric disease is stable and that the psychiatrist has approved the surgical procedure. In addition, the surgeon must feel that the patient is a good candidate after the visit and a discussion of the procedure, benefits, and risks.
However, in daily surgical practice, some psychiatric patients may not have been diagnosed or may have deliberately concealed their illness. This makes for a poorer physicianpatient relationship and can affect the efficacy of therapy. 20, 21 Our study is limited, in that undiagnosed patients were excluded.
When an undiagnosed psychiatric disorder is suspected, we advise against immediate surgery. The patient should first be diagnosed with the help of information provided by family members or the primary care physician and then referred to a psychiatrist for appropriate treatment before undergoing surgery.
We must also remember that psychiatric patients often take psychoactive drugs, which can present a number of adverse effects and interactions. The most important issue for the refractive surgeon is that many drugs have a more or less significant anticholinergic component. These drugs can produce mydriasis, make miosis difficult, and inhibit tear secretion. Such effects are usually accompanied by dry mouth, which is easily detectable. Consumption of cannabis (widespread among young people) produces a miotic effect lasting several hours.
If local anesthesia is administered with sedation, it is important to remember that high-dose benzodiazepines inhibit the respiratory center and that most selective serotonin reuptake inhibitors affect different subtypes of cytochrome P450, thereby reducing the clearance of certain substances. Other drugs, such as lithium or some anticonvulsants, may also produce neuro-ophthalmologic side effects, which are usually accompanied by signs and symptoms that guide diagnosis.
Although a series of objective measures of refractive outcome is hardly an indication of satisfaction in this population, one would expect the refractive outcomes to be identical to those of the general population. It was reasonable to expect that satisfaction with treatment or outcome might be affected by the psychiatric disease. However, our results show that patients tolerated the procedures well and were satisfied with the outcome.
Our study shows that patients with severe psychiatric disorders (schizophrenia, obsessive-compulsive disorder, and bipolar disorder) who are stable can be good candidates for LASIK. It is important to detect and exclude patients who are not diagnosed or reported. We should take into account the presence of anticholinergic effects that can interfere with surgery and take appropriate action. 
